Rapidly increasing maternal morbidity and death continue to be mostly attributed to cardiovascular disease. Whenever both the pregnant woman and the developing foetus are exposed to several possible difficulties, various physiological changes of gestation happen. Women who have pre-existing cardiac conditions, such as congenital abnormalities, angina pectoris, coronary artery disease and aortopathies, need to undergo multidisciplinary testing, counselling, and optimization before getting pregnant. They also need to be closely monitored and have their medication needs managed. Close monitoring is crucial for patients who developed cardiac conditions like congestive heart failure, preeclampsia, cardiomyopathy, coronary events, or arrhythmia while pregnant. The signs of a cardiac issue during pregnancy include- fatigue, chest pain, shortness of breath, fainting, difficulty breathing while sleeping.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation